Skip to content

Author

S. Ramalho

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Pathologic complete response and survival outcomes after carboplatin-based neoadjuvant chemotherapy in triple-negative breast cancer: a real-world cohort

Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with a high risk of early relapse. The addition of carboplatin to neoadjuvant chemotherapy increases pathologic complete response (pCR) rates, which are strongly associated with survival outcomes. In the Brazilian pu...

G. Tavares, S. Ramalho, L. Silva et al. · 0 citations
Open access 2026

Adjuvant capecitabine in residual triple-negative breast cancer after carboplatin-based neoadjuvant chemotherapy: a real-world cohort

Introduction: Patients with triple-negative breast cancer (TNBC) who do not achieve pathologic complete response (pCR) after neoadjuvant chemotherapy have a worse prognosis. Adjuvant capecitabine has demonstrated benefit in selected populations, but its role after prior carboplatin exposure remains uncertain, particula...

G. Tavares, S. Ramalho, L. Silva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.